Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biovail Inks License Agreement With Kyowa Hakko Kirin
BLS has acquired the US and Canadian rights to commercialise products containing istradefylline, a new chemical entity targeted for the treatment of Parkinson’s disease. As per the terms
BLS has acquired the US and Canadian rights to commercialise products containing istradefylline, a new chemical entity targeted for the treatment of Parkinson’s disease. As per the terms
Motavizumab (proposed INN, trade name Numax) is a humanised monoclonal antibody. It is being investigated by MedImmune for the prevention of respiratory syncytial virus infection in high-risk infants.
Under the terms of the agreement, Oramed will out-license technology to Entera for the development of oral delivery drugs for certain indications. The out-licensed technology differs from Oramed’s
The Weizmann and Niigata patents cover the use of transglutaminase inhibitors, a class of molecules chemically similar to Cysteamine, in the potential treatment of Huntington’s Disease and other
Biomoda currently is conducting clinical trials of its CyPath labeling solution, an inexpensive, noninvasive assay designed to identify early-stage lung cancer by binding to cancer cells and causing
Recently, FDA requested manufacturers to revise their drug labels because of an increased risk of severe exacerbation of asthma symptoms, leading to hospitalizations, in pediatric and adult patients,
BD Diagnostics said that the BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer walkaway automation to accommodate varying workloads
Advair contains fluticasone and salmeterol. Fluticasone is a steroid. Advair prevents the release of substances in the body that cause inflammation. Salmeterol is a bronchodilator. It works by
BioGaia said that the launch of the product is estimated at the end of 2011 following relevant local registration which will be taken care of by Asia United.
Life Technologies said that the pilot study builds upon a research trial announced earlier this year in association with TGen and US Oncology, to sequence the genomes of